查找临床试验
已按「淋巴瘤」检索，对应国际通用词 lymphoma
共找到 1,722 项正在招募的试验
数据更新于 22:08，每 5 分钟自动同步A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
United States
年龄 18 Years – 不限
Lyell Immunopharma, Inc.
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
United States、Puerto Rico
年龄 18 Years – 80 Years
VM Oncology, LLC
Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients
United States
年龄 不限 – 30 Years
Washington University School of Medicine
Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia
Denmark
年龄 1 Year – 45 Years
Copenhagen University Hospital, Rigshospitalet
CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma
China
年龄 18 Years – 75 Years
Chinese PLA General Hospital
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
United States、Bosnia and Herzegovina、Bulgaria、Croatia、Hungary 等 8 国
年龄 18 Years – 不限
Grifols Therapeutics LLC
Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia
South Korea
年龄 1 Year – 19 Years
Jae Wook Lee
Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma
Singapore
年龄 21 Years – 99 Years
National Cancer Centre, Singapore
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
United States
年龄 18 Years – 不限
Memorial Sloan Kettering Cancer Center
PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
China
年龄 18 Years – 不限
Institute of Hematology & Blood Diseases Hospital, China
Real-life Experience of Brentuximab Vedotin Plus CHP as First-line Treatment of CD30+ Peripheral T-cell Lymphomas in Spain
Spain
年龄 18 Years – 不限
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
United States、Australia、Belgium、Denmark、Italy
年龄 18 Years – 不限
Incyte Corporation